Koivisto Simo-Pekka, Wistbacka Jan-Ola, Rimpiläinen Riikka, Nissinen Juha, Loponen Pertti, Teittinen Kari, Biancari Fausto
Department of Anesthesiology, Vaasa Central Hospital, Vaasa, Finland.
Perfusion. 2010 Mar;25(2):65-70. doi: 10.1177/0267659110364443. Epub 2010 Feb 23.
To review our results with the use of miniaturized cardiopulmonary bypass (Mini-CPB) versus conventional cardiopulmonary bypass (C-CPB) in high-risk patients (additive EuroSCORE>or=6) who have undergone coronary artery bypass graft surgery (CABG).
This study includes a consecutive series of 236 patients with an additive EuroSCORE>or=6 who underwent CABG, employing either C-CPB or Mini-CPB. Propensity score analysis was performed.
The study groups had similar EuroSCOREs. Stroke rate was significantly higher among C-CPB patients (5.4% vs. 0%, p=0.026). In-hospital mortality (4.8% vs. 3.4%, p=0.75) and combined adverse end-point rate were higher in C-CPB patients (20.4% vs. 13.5%, p=0.18). Postoperative bleeding and need for transfusion were similar in the study groups, but re-sternotomy for bleeding was more frequent among C-CPB patients (4.8% vs. 1.1%, p=0.26). Seventy-four propensity matched pairs had similar immediate postoperative results: C-CPB patients had higher mortality (6.8% vs. 4.1%, p=0.72), stroke (5.4% vs. 0%, p=0.12) and combined adverse end-point rates (27.0% vs. 16.2%, p=0.11), but such differences failed to reach statistical significance.
Mini-CPB achieved somewhat better results than C-CPB in these high-risk patients undergoing isolated CABG. This study confirmed that cerebral protection could be the main benefit associated with the use of Mini-CPB.
回顾我们在高危患者(累计欧洲心脏手术风险评估系统[EuroSCORE]≥6)冠状动脉旁路移植术(CABG)中使用小型体外循环(Mini-CPB)与传统体外循环(C-CPB)的结果。
本研究纳入连续236例累计EuroSCORE≥6且接受CABG的患者,采用C-CPB或Mini-CPB。进行了倾向评分分析。
研究组的EuroSCORE相似。C-CPB患者的卒中发生率显著更高(5.4%对0%,p=0.026)。C-CPB患者的住院死亡率(4.8%对3.4%,p=0.75)和联合不良终点发生率更高(20.4%对13.5%,p=0.18)。研究组术后出血情况和输血需求相似,但C-CPB患者因出血行再次胸骨切开术更为频繁(4.8%对1.1%,p=0.26)。74对倾向匹配的患者术后即刻结果相似:C-CPB患者死亡率更高(6.8%对4.1%,p=0.72)、卒中发生率更高(5.4%对0%,p=0.12)以及联合不良终点发生率更高(27.0%对16.2%,p=0.11),但这些差异未达到统计学显著性。
在这些接受单纯CABG的高危患者中,Mini-CPB的结果略优于C-CPB。本研究证实脑保护可能是使用Mini-CPB的主要益处。